HK1115325A1 - Method for treatment or prevention of conditions caused by gram-positive bacteria - Google Patents
Method for treatment or prevention of conditions caused by gram-positive bacteriaInfo
- Publication number
- HK1115325A1 HK1115325A1 HK08111119.5A HK08111119A HK1115325A1 HK 1115325 A1 HK1115325 A1 HK 1115325A1 HK 08111119 A HK08111119 A HK 08111119A HK 1115325 A1 HK1115325 A1 HK 1115325A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- gram
- prevention
- treatment
- positive bacteria
- conditions caused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71207505P | 2005-08-29 | 2005-08-29 | |
PCT/US2006/033581 WO2007027636A2 (en) | 2005-08-29 | 2006-08-25 | Method for treatment or prevention of conditions caused by gram-positive bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1115325A1 true HK1115325A1 (en) | 2008-11-28 |
Family
ID=37809418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08111119.5A HK1115325A1 (en) | 2005-08-29 | 2008-10-08 | Method for treatment or prevention of conditions caused by gram-positive bacteria |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070049554A1 (xx) |
EP (1) | EP1933856A4 (xx) |
JP (1) | JP5432525B2 (xx) |
KR (1) | KR101413361B1 (xx) |
CN (1) | CN101252942B (xx) |
AP (1) | AP2626A (xx) |
AU (1) | AU2006284990B2 (xx) |
BR (1) | BRPI0615411A2 (xx) |
CA (1) | CA2621066C (xx) |
HK (1) | HK1115325A1 (xx) |
NO (1) | NO20080637L (xx) |
NZ (1) | NZ565590A (xx) |
RU (1) | RU2391985C2 (xx) |
UA (1) | UA89545C2 (xx) |
WO (1) | WO2007027636A2 (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE112010003355T5 (de) * | 2009-08-21 | 2012-07-12 | Targeted Delivery Technologies Ltd. | Veskuläre Formulierungen |
GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
US9023833B2 (en) | 2012-12-18 | 2015-05-05 | Sepsicure, LLC | Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds |
WO2014145303A1 (en) * | 2013-03-15 | 2014-09-18 | Pharmagenesis, Inc. | Intravenous emulsions of triptolide as immunomodulators and anticancer agents i |
EP2805612A1 (en) | 2013-05-22 | 2014-11-26 | University of Graz | Lysophospholipids against American Foulbrood |
LT3316856T (lt) | 2015-06-30 | 2021-07-12 | Sequessome Technology Holdings Limited | Mišrios kompozicijos |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2220331A (en) * | 1936-02-28 | 1940-11-05 | Schering Corp | Remedy for infection by cocci and process of manufacturing it |
US4072575A (en) * | 1976-05-03 | 1978-02-07 | Mcdonnell Douglas Corporation | Broth and method for detecting E. coli in mixed water samples |
US4340671A (en) * | 1977-08-29 | 1982-07-20 | Mcdonnell Douglas Corporation | E. coli sensitivity broth |
JPS61172826A (ja) * | 1985-01-25 | 1986-08-04 | Tanabe Seiyaku Co Ltd | 魚類連鎖球菌症の予防・治療用組成物 |
JPS6259214A (ja) * | 1985-09-09 | 1987-03-14 | Kyowa Yakuhin Kk | 水生動物感染症起因菌の抗菌剤 |
NO178843C (no) * | 1988-07-11 | 1996-06-19 | Sspl Sa Safe Sex Prod Licens | Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer |
JPH0672882A (ja) * | 1991-07-29 | 1994-03-15 | Sennosuke Tokumaru | インターフェロン−β産生増強剤 |
US6306621B1 (en) * | 1991-11-18 | 2001-10-23 | The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency | Membrane filter agar medium for simultaneous detection of total coliforms and E. coli |
US5587366A (en) * | 1992-08-12 | 1996-12-24 | The Rogosin Institute | Compositions useful in prophylaxis and therapy of endotoxin related conditions |
US5674855A (en) * | 1992-08-12 | 1997-10-07 | The Rogosin Institute | Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
US5344822A (en) * | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
JPH07277986A (ja) * | 1994-04-08 | 1995-10-24 | Kazuo Hosoya | 胆汁酸塩を主成分とするメチシリン耐性黄色ブドウ球菌用抗菌 剤成分 |
US5932536A (en) * | 1994-06-14 | 1999-08-03 | The Rockefeller University | Compositions for neutralization of lipopolysaccharides |
JPH1017476A (ja) * | 1996-06-28 | 1998-01-20 | Nippon Seiyaku Kk | 敗血症用非経口製剤及びそれによる予防及び治療方法 |
US6165997A (en) * | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
US9040078B2 (en) * | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
US7811999B2 (en) * | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
CU22789A1 (es) * | 2000-06-29 | 2002-07-24 | Ct Nac Biopreparados | Mezcla nutritiva y procedimiento para la identificación y recuento temprano de organismos gram-negativos |
AU2002319961A1 (en) * | 2001-07-27 | 2003-02-17 | N.V. Nutricia | Enteral compositions for the prevention and/or treatment of sepsis |
US20030032674A1 (en) * | 2001-08-13 | 2003-02-13 | Hwang Daniel H. | Use of unsaturated fatty acids to treat severe inflammatory diseases |
US20030143658A1 (en) * | 2002-01-28 | 2003-07-31 | Casella Linda J. Richardson | Rapid methods and devices for the detection of coliform and the detection and confirmation of E. coil |
US20080318870A1 (en) * | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
-
2006
- 2006-08-25 CA CA2621066A patent/CA2621066C/en active Active
- 2006-08-25 RU RU2008111897/14A patent/RU2391985C2/ru not_active IP Right Cessation
- 2006-08-25 AU AU2006284990A patent/AU2006284990B2/en not_active Ceased
- 2006-08-25 BR BRPI0615411-5A patent/BRPI0615411A2/pt not_active Application Discontinuation
- 2006-08-25 EP EP06813861A patent/EP1933856A4/en not_active Ceased
- 2006-08-25 JP JP2008529172A patent/JP5432525B2/ja not_active Expired - Fee Related
- 2006-08-25 WO PCT/US2006/033581 patent/WO2007027636A2/en active Application Filing
- 2006-08-25 CN CN200680031406XA patent/CN101252942B/zh not_active Expired - Fee Related
- 2006-08-25 AP AP2008004344A patent/AP2626A/xx active
- 2006-08-25 NZ NZ565590A patent/NZ565590A/en not_active IP Right Cessation
- 2006-08-25 US US11/510,094 patent/US20070049554A1/en not_active Abandoned
- 2006-08-25 KR KR1020087005056A patent/KR101413361B1/ko active IP Right Grant
- 2006-08-25 UA UAA200801080A patent/UA89545C2/uk unknown
-
2008
- 2008-02-05 NO NO20080637A patent/NO20080637L/no not_active Application Discontinuation
- 2008-10-08 HK HK08111119.5A patent/HK1115325A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP5432525B2 (ja) | 2014-03-05 |
AP2626A (en) | 2013-03-26 |
KR101413361B1 (ko) | 2014-06-27 |
AU2006284990A1 (en) | 2007-03-08 |
CA2621066C (en) | 2011-11-29 |
WO2007027636A2 (en) | 2007-03-08 |
CN101252942B (zh) | 2010-12-22 |
WO2007027636A3 (en) | 2007-09-07 |
US20070049554A1 (en) | 2007-03-01 |
EP1933856A4 (en) | 2008-11-19 |
NO20080637L (no) | 2008-03-26 |
CA2621066A1 (en) | 2007-03-08 |
UA89545C2 (uk) | 2010-02-10 |
KR20080066914A (ko) | 2008-07-17 |
NZ565590A (en) | 2010-07-30 |
JP2009506120A (ja) | 2009-02-12 |
RU2391985C2 (ru) | 2010-06-20 |
CN101252942A (zh) | 2008-08-27 |
BRPI0615411A2 (pt) | 2012-12-04 |
AU2006284990B2 (en) | 2011-01-06 |
RU2008111897A (ru) | 2009-10-10 |
EP1933856A2 (en) | 2008-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704909B (en) | Method of treatment or prophylaxis | |
IL187581A0 (en) | Compounds for the treatment of multi-drug resistant bacterial infections | |
IL187450A0 (en) | Methods for treating fibrotic conditions | |
HK1142523A1 (en) | Composition for prophylaxis or treatment of urinary system infection | |
IL186895A0 (en) | Methods for treating eye conditions | |
EP2032131A4 (en) | Methods of Treatment | |
EP1984081A4 (en) | PROCESS FOR OXIDATIVE TREATMENT | |
EP1940437A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF BACTERIA | |
EP2331093A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR REDUCING TOXICITY AND TREATMENT PREVENTING DISEASES | |
EP2015765A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS | |
EP1855729A4 (en) | sterilization | |
GB0610746D0 (en) | Method of treatment | |
GB0513096D0 (en) | Treatment of microbial infections | |
HK1115325A1 (en) | Method for treatment or prevention of conditions caused by gram-positive bacteria | |
TWI365875B (en) | Prevention of bacterial contamination | |
EP1988060A4 (en) | METHOD FOR TREATING WASTEWATER | |
EP1901770A4 (en) | METHOD FOR TREATING GROWTH TROUBLESHOOTING | |
ZA200706873B (en) | Method of inhibiting the growth of microorganisms | |
GB0608357D0 (en) | Method for treating effluent | |
ZA200709915B (en) | Methods for treating fibrotic conditions | |
EP2280698A4 (en) | PROCESS FOR INHIBITING BACTERIAL GROWTH | |
GB0610330D0 (en) | Method for preservation of micro-organisms | |
EP2094385A4 (en) | METHOD OF WASTE WATER TREATMENT | |
GB2442705B (en) | Inactivation of gram-positive bacteria | |
GB0624439D0 (en) | Technique for treatment of gall-and kidney-stones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200825 |